430 related articles for article (PubMed ID: 23840140)
1. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
2. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
[TBL] [Abstract][Full Text] [Related]
7. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification for predicting postoperative recurrence/metastasis of colorectal cancer by grade of venous invasion coupled with histological subtype.
Imai Y; Ichinose M
BMC Gastroenterol; 2022 Feb; 22(1):79. PubMed ID: 35197005
[TBL] [Abstract][Full Text] [Related]
9. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
[TBL] [Abstract][Full Text] [Related]
10. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.
Bu XD; Li N; Tian XQ; Li L; Wang JS; Yu XJ; Huang PL
World J Gastroenterol; 2010 Aug; 16(32):4089-94. PubMed ID: 20731025
[TBL] [Abstract][Full Text] [Related]
13. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.
Kim DH; Kim JW; Cho JH; Baek SH; Kakar S; Kim GE; Sleisenger MH; Kim YS
Int J Oncol; 2005 Oct; 27(4):957-64. PubMed ID: 16142311
[TBL] [Abstract][Full Text] [Related]
14. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).
Buyuk M; Ozluk Y; Bakkaloglu DV; Ozkan B; Firat P; Yilmazbayhan D
Turk Patoloji Derg; 2023; 39(1):64-74. PubMed ID: 36367122
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma.
Albarracin CT; Jafri J; Montag AG; Hart J; Kuan SF
Hum Pathol; 2000 Jun; 31(6):672-7. PubMed ID: 10872659
[TBL] [Abstract][Full Text] [Related]
17. A minor (<50%) signet-ring cell component associated with poor prognosis in colorectal cancer patients: a 26-year retrospective study in China.
Tan Y; Fu J; Li X; Yang J; Jiang M; Ding K; Xu J; Li J; Yuan Y
PLoS One; 2015; 10(3):e0121944. PubMed ID: 25789685
[TBL] [Abstract][Full Text] [Related]
18. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
Debunne H; Ceelen W
Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
[TBL] [Abstract][Full Text] [Related]
19. Notch3 signaling is associated with MUC5AC expression and favorable prognosis in patients with small intestinal adenocarcinomas.
Eom DW; Hong SM; Kim J; Kim G; Bae YK; Jang KT; Yu E
Pathol Res Pract; 2014 Aug; 210(8):501-7. PubMed ID: 24810798
[TBL] [Abstract][Full Text] [Related]
20. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas.
Losi L; Scarselli A; Benatti P; Ponz de Leon M; Roncucci L; Pedroni M; Borghi F; Lamberti I; Rossi G; Marino M; Ponti G; Zangardi G; Menigatti M; Di Gregorio C
Pathol Res Pract; 2004; 200(5):371-7. PubMed ID: 15239345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]